In vivo osteogenic capability of cultured allogeneic bone in porous hydroxyapatite: Immunosuppressive and osteogenic potential of FK506 in vivo

Journal of Bone and Mineral Research

Volumn 15, Issue 6, 2000, Pages 1147-1157

  Yoshikawa, Takafumi ^a   Nakajima, H ^a   Yamada, E ^a   Akahane, M ^a   Dohi, Y ^a   Ohgushi, H ^a   Tamai, S ^a   Ichijima, K ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Dexamethasone; FK506; Hydroxyapatite; Marrow cell; Osteogenesis; Tissue culture

Indexed keywords

ALKALINE PHOSPHATASE; DEXAMETHASONE; GLYCEROL 2 PHOSPHATE; HYDROXYAPATITE; INTERPORE 500; MESSENGER RNA; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOGRAFT; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CONTROLLED STUDY; FEMUR; HISTOLOGY; IMPLANTATION; MALE; NONHUMAN; RAT;

EID: 0034082289     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.6.1147     Document Type: Article

References (44)

1. Maniatopoulos C, Sodek J, Melcher AH 1988 Bone formation in vitro by stromal cells obtained from marrow of young adult rats. Cell Tissue Res 254:317-330.
2. Davies JE, Lowenberg B, Shiga A 1990 The bone-titanium interface in vitro. J Biomed Mater Res 24:1289-1306.
3. Davies JE, Chernecky R, Lowenberg B, Shiga A 1991 Deposition and resorption of calcified matrix in vitro by rat marrow cell. Cells Mater 1:3-15.
4. Davies JE, Ottensmeyer O, Shen X, Hashimoto M, Peel SAF 1991 Early extracellular matrix synthesis. In: Davies JE (ed.) The Bone-Biomaterial Interface. University of Toronto Press, Toronto, Canada, pp. 214-228.
5. Ohgushi H, Dohi Y, Katsuda T, Tamai S, Tabata T, Suwa Y 1996 In vitro bone formation by rat marrow cell culture. J Biomed Mater Res 32:333-340.
6. Yao K-L, Todescan RJ, Sodek J 1994 Temporal changes in matrix protein synthesis and m-RNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J Bone Miner Res 9:231-240.
7. Yoshikawa T, Ohgushi H, Dohi Y, Davies JE 1997 Viable bone formation in porous hydroxyapatite: Marrow-derived in vitro bone on the surface of ceramics. Biomed Mater Eng 71:49-58.
8. Yoshikawa T, Ohgushi H, Tamai S 1996 Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. J Biomed Mater Res 32:481-492.
9. Yoshikawa T, Ohgushi H, Nakajima H, Yamada E, Ichijima K, Tamai S, Ohta T 2000 In vivo osteogenic durability of cultured bone in porous ceramics: A novel method to autogenous bone graft substitute Transplantation 69:128-134.
10. Yoshikawa T, Ohgushi H, Uemura T, Nakajima H, Ichijima K, Tamai S, Tateishi T 1998 Human marrow cells-derived cultured bone in porous ceramics. Biomed Mater Eng 8:311-320.
11. Yoshikawa T, Peel SA, Gladstone JR, Davies JE 1997 Biochemical analysis of the response in rat bone marrow cell cultures to mechanical stimulation. Biomed Mater Eng 7:369-377.
12. Yoshikawa T, Ohgushi H, Okumura M, Tamai S, Dohi Y, Moriyama T 1992 Biochemical and histological sequences of membranous ossification in ectopic site. Calcif Tissue Int 50:184-188.
13. Ohgushi H, Goldberg VM, Caplan AI 1988 Heterotopic osteogenesis in porous ceramics induced by marrow cells. J Orthop Res 7:568-578.
14. Spencer CM, Goa KL, Gillis JC 1997 Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 54:925-975.
15. Fung JJ, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Jordan M, Armitage J, Jain A, Alessiani M, Martin M 1990 Overview of FK506 in transplantation. Clin Transpl 115-121.
16. Park KM, Hay JE, Lee SG, Lee YJ, Wiesner RH, Porayko MK, Krom RA 1996 Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. Transplant Proc 28:1738-1740.
17. Bowman AR, Sass DA, Dissanayake IR, Ma YF, Liang H, Yan Z, Jee WS, Epstein S 1997 The role of testosterone in cyclosporine-induced osteopenia. J Bone Miner Res 12:607-615.
18. Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, Ma YF, Jee WS, Epstein S 1995 Rapamycin: A bone sparing immunosuppressant? J Bone Miner Res 10: 760-768.
19. Cvetkovic M, Mann GN, Romero DF, Liang XG, Ma Y, Jee WS, Epstein S 1994 The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 57:1231-1237.
20. Klein L, Lemel MS, Wolfe MS, Shaffer J 1994 Cyclosporin A does not affect the absolute rate of cortical bone resorption at the organ level in the growing rat. Calcif Tissue Int 55:295-301.
21. Holmes RE, Bucholz RW, Mooney V 1986 Porous hydroxyapatite as a bone-graft substitute in metaphyseal defects. A histometric study. J Bone Joint Surg 68A:904-911.
22. Gill IIITJ, Kunz HW, Misra DN, Hassett ALC 1987 The major histocompatibility complex of the rat. Transplantation 43:773-785.
23. Zalewski AA, Fahy GM, Azzam NA, Azzam RN 1992 The fate of cryopreserved nerve isografts and allografts in normal and immunosuppressed rats. J Comp Neurol 331:134-147.
24. Sempuku T, Ohgushi H, Okumura M, Tamai S 1996 Osteogenic potential of allogeneic rat marrow cells in porous hydroxyapatite ceramics: A histological study. J Orthop Res 14:907-913.
25. Akahane M, Ohugushi H, Yoshikawa T, Sempuku T, Tamai S, Tabata S, Dohi Y 1999 Osteogenic phenotype expression of allogenic rat marrow cells in porous hydroxyapatite ceramics. J Bone Miner Res 14:561-568.
26. Reddi AH, Sullivan NS 1980 Matrix-induced endochondral bone differentiation: Influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone. Endocrinology 107:1291-1299.
27. Ohta T, Azuma Y, Kiyoki M, Eguchi H, Arita M, Hosoda K, Tsukamoto Y, Nakamura T 1996 Measurement of intact rat osteocalcin in osteoblast (ROS17/2.8) cells and in ovariectomized rats with a sandwich enzyme immunoassay. Calcif Tissue Int 59:283-290.
28. Inoue K, Ohgushi H, Yoshikawa T, Tamai S, Dohi Y, Hosoda K, Ohta T 1995 Measurement of intact bone Gla protein contents in porous hydroxyapatite. In: Wilson J, Hench LL, Greenspan D (eds.) Bioceramics. Elsevier, New York, vol 8. pp. 99-102.
29. Fujiwara K, Yasuno M, Kitagawa T 1981 Immunoassay for pepleomycin, a new bleomycin analog. Cancer Res 41:4121-4126.
30. Ohgushi H, Dohi Y, Tamai S, Tabata S 1993 Osteogenic differentiation of marrow stromal stem cells in porous hydroxyapatite ceramics. J Biomed Mater Res 27:1401-1407.
31. Dohi Y, Ohgushi H, Tabata S, Yoshikawa T, Dohi K, Moriyama T 1992 Osteogenesis associated with bone gla protein gene expression in diffusion chambers by bone marrow cells with demineralized bone matrix. J Bone Miner Res 7:1173-1180.
32. Perico N, Remuzzi G 1997 Prevention of transplant rejection: Current treatment guidelines and future developments. Drugs 54:533-570.
33. Yoshikawa T, Ohgushi H, Akahane M, Tamai S, Ichijima K 1998 Analysis of gene expression in osteogenic cultured marrow/hydroxyapatite construct implanted at ectopic sites: A comparison with osteogenic ability of cancellous bone. J Biomed Mater Res 41:568-573.
34. Inoue K, Ohgushi H, Yoshikawa T, Sempuku T, Tamai S, Dohi Y 1997 The effect of aging on bone formation in porous hydroxyapatite. Biochemical and histological analysis. J Bone Miner Res 12:989-994.
35. Tsuji T, Hughes FJ, McCulloch CAG, Melcher AH 1990 Effect of donor age on osteogenic cells of rat bone marrow in vitro. Mech Ageing Dev 51:121-132.
36. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL 1991 Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815.
37. Liu J, Albers MW, Wandless TJ, Luan S, Alberg DG, Belshaw PJ, Cohen P, MacKintosh C, Klee CB, Schreiber SL 1992 Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31:3896-3901.
38. Clipstone NA, Crabtree GR 1992 Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695-697.
39. Brown EJ, Alters MW, Shin TB, Ichikawa K, Keith CT, Lane WAS, Schreiber SL 1994 A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369:756-758.
40. Chen Y, Chen H, Rhoad AE, Warner L, Caggiano TJ, Failli A, Zhang H, Hsiao CL, Nakanishi K, Molnar-Kimber KL 1994 A putative sirolimus (rapamycin) effector protein. Biochem Biophys Res Commun 203:1-7.
41. Nakajima H, Yoshikawa T, Ohgushi H, Mishima K, Dohi Y, Tabata S, Tamai S, Yamada E, Ichijima K Cycrosporin A and FK 506, calcineurin inhibiting immunosuppressants, provoke osteoblastic differentiation of marrow stromal stem cells. J Biomed Mater Res (submitted).
42. Bowman AR, Sass DA, Dissanayake IR, Ma YF, Liang H, Yan Z, Jee WS, Epstein S 1997 The role of testosterone in cyclosporine-induced osteopenia. J Bone Miner Res 12:607-615.
43. Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, Ma YF, Jee WS, Epstein S 1995 Rapamycin: A bone sparing immunosuppressant? J Bone Miner Res 10: 760-768.
44. Cvetkovic M, Mann GN, Romero DF, Liang XG, Ma Y, Jee WS, Epstein S 1994 The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 57:1231-1237.